City of Hope

www.cityofhope.org

 

City of Hope
T

Tolerability of BTKi in R/R MCL

By City of Hope FEATURING Tycel Phillips
By City of Hope FEATURING Tycel Phillips
193 views
October 12, 2022
This video was recorded prior to FDA approval of Pirtobrutinib on January 26, 2023 in ...
read more ↘
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
Lymphoma
10:57
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Mosunetuzumab + Polatuzumab Vedotin in Pts …

Feat. E. Budde
10:21
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: HL

Feat. A. Herrera
19:32
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Tailoring Therapy for PTCL

Feat. J. Zain
10:33
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: A Multidisciplinary Approach to the Management of Mycosis…

Feat. C. Querfeld
06:21
City of Hope

Cardiac Safety of Zanubrutinib vs. Other BTKis in CLL

Feat. A. Danilov
12:24
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Real-World Outcomes of Brexu-Cel for R/R …

Feat. S. Kambhampati
06:50
ecancer

ASCO® 2023 Insights: "S1826 Study Summary - Nivolumab-AVD vs. B…

Feat. A. Herrera
06:16
City of Hope

Current Perspective on CAR-T Therapy in Mantle Cell Lymphoma

Feat. A. Danilov
07:48
City of Hope

Tolerability of BTKi in R/R MCL

Feat. T. Phillips
18:31
City of Hope

Novel Treatment Options for DLBCL - Overview of Targeted Therapies a…

Feat. J. Zain
30:08
City of Hope

Advances in Therapy in Cutaneous T Cell Lymphoma

Feat. C. Querfeld